Posttransplant de novo dsa and ndsa affect gvhd, os, and dfs after haplo-hsct in patients without pre-existing hla antibodies of hematological malignancies

HIGHLIGHTS

• who: Lan Wang et al. from the Jiaotong, China have published the paper: Posttransplant de novo DSA and NDSA affect GvHD, OS, and DFS after haplo-HSCT in patients without pre-existing HLA antibodies of hematological malignancies, in the Journal: (JOURNAL) of 30/01/2021
• what: This study showed that post-transplantation dynamic testing of patients without preexisting HLA antibodies will detect de novo HLA antibodies after HSCT. Previous studies in organ transplantation and the study have shown that de novo HLA antibodies will affect graft rejection and survival. The main reason why de novo . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.